Alkem Laboratories Launches NeuCeno for Partial-Onset Seizure Treatment in India
Alkem Laboratories Ltd 路 Press Release 路 16 Sept 2026, 5:19 pm
Alkem Laboratories Launches NeuCeno for Partial-Onset Seizure Treatment in India On 16th Sep'26, Alkem Laboratories announced the launch of NeuCeno (cenobamate) in India for treating partial-onset seizures in adults, marking the molecule's first entry into the domestic market. NeuCeno is a once-daily oral anti-seizure medication available in dosages ranging from 12.5 mg to 200 mg. Clinical data demonstrated up to a 78% reduction in seizure frequency, with up to 30% of patients achieving seizure freedom during the maintenance phase, targeting an estimated 9.4 million epilepsy patients across India.
Original exchange filing (PDF)
More announcements from Alkem Laboratories Ltd
- With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the '' Q2 and H1FY27 Earnings Conference Call'' .... 路 13 Nov 2026
- We wish to inform you that the Company has appointed Mr. Gopal Kothari as the CFO and KMP of the Company wef 2nd Dec, 2026. 路 12 Nov 2026
- Pl find enclosed press release and analyst presentation on Q2 and H1FY27 earnings and business updates of the Company 路 12 Nov 2026
- Pl find enclosed unaudited financial results along with Limited Review Report of the Company for quarter and half year ended 30th Sept, 2026. 路 12 Nov 2026
- Alkem Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 12 Nov 2026
- Please find enclosed herewith the outcome of Board meeting dated 12th Nov, 2026. The meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 13.40. 路 12 Nov 2026
- Please find attached herewith intimation of incorporation of subsidiary in the form of Joint Venture. 路 09 Nov 2026
- With reference to your email regarding the captioned corporate announcement submitted by the Company on 03rd November, 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure .... 路 05 Nov 2026
